China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- The return capsule of the Shenzhou XX spaceship has safely returned to Earth
- Factory blast in China's Inner Mongolia kills 2, missing rises to 8, 84 injured
- Urumqi to host youth winter games
- China's satellite data shows iceberg A23a in final stage of disintegration
- Chinese woman, British man marry in Ming-style ceremony
- Guangzhou to screen all seniors in care homes for early signs of dementia
